Ellen Napier

Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas

Guido Ghilardi, Elise A. Chong, Jakub Svoboda et al. · Annals of Oncology · 2022 · 97 citations · Full text

Medicine, Oncology, Pharmacotherapy +7

Sequential Anti-CD19 Directed Chimeric Antigen Receptor Modified T-Cell Therapy (CART19) and PD-1 Blockade with Pembrolizumab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Elise A. Chong, Jakub Svoboda, Sunita D. Nasta et al. · Blood · 2018 · 85 citations

Life Sciences, Immunology, Oncology +14

A feasibility study of Dignity Psychotherapy delivered via telemedicine

Steven D. Passik, Kenneth L. Kirsh, SUZANNE LEIBEE et al. · Palliative & Supportive Care · 2004 · 39 citations

Nursing, Oncology, Counseling Psychology +14

Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines

Guido Ghilardi, Luca Paruzzo, Jakub Svoboda et al. · Blood Advances · 2023 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Elise A. Chong, Elicia Penuel, Ellen Napier et al. · Blood Advances · 2024 · 10 citations · Full text

Life Sciences, Immunology, Oncology +17